| Lastest Insider Transactions Of Neumora Therapeutics, Inc. ( NMRA ) |
| Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
| NMRA | Neumora Therapeutics, Inc. | Aurora Daljit Singh | See Remarks | 2026-08-17 | Sell | 277,773 | 1.55 | 431,674 | 2026-08-19 19:17:14 |
| NMRA | Neumora Therapeutics, Inc. | Aurora Daljit Singh | See Remarks | 2026-08-17 | Option Exercise | 243,753 | 0.72 | 175,502 | 2026-08-19 19:17:14 |
| NMRA | Neumora Therapeutics, Inc. | Aurora Daljit Singh | See Remarks | 2026-02-17 | Sell | 6,165 | 3.56 | 21,917 | 2026-02-19 17:07:13 |
| NMRA | Neumora Therapeutics, Inc. | Pinto Joshua | President | 2026-02-17 | Sell | 5,967 | 3.54 | 21,093 | 2026-02-19 17:06:16 |
| NMRA | Neumora Therapeutics, Inc. | BERNS PAUL L | See Remarks | 2026-02-17 | Sell | 9,819 | 3.51 | 34,459 | 2026-02-19 17:05:16 |
| NMRA | Neumora Therapeutics, Inc. | Milligan Michael Lee | See Remarks | 2026-02-17 | Sell | 1,436 | 3.56 | 5,119 | 2026-02-19 17:04:21 |
| NMRA | Neumora Therapeutics, Inc. | Aurora Daljit Singh | See Remarks | 2025-11-11 | Sell | 114,703 | 2.68 | 307,026 | 2025-11-13 16:39:15 |
| NMRA | Neumora Therapeutics, Inc. | Burow Kristina | Directior 10% Owner | 2025-10-27 | Buy | 1,915,700 | 2.61 | 4,999,977 | 2025-10-29 19:22:24 |
| NMRA | Neumora Therapeutics, Inc. | ARCH Venture Partners XII, LLC | 10% Owner | 2025-10-27 | Buy | 1,915,700 | 2.61 | 4,999,977 | 2025-10-29 19:21:13 |
| NMRA | Neumora Therapeutics, Inc. | ARCH Venture Partners X, LLC | 10% Owner | 2025-10-27 | Buy | 1,915,700 | 2.61 | 4,999,977 | 2025-10-29 19:19:14 |
| NMRA | Neumora Therapeutics, Inc. | BERNS PAUL L | See Remarks | 2025-02-18 | Sell | 13,871 | 1.69 | 23,468 | 2025-02-20 17:14:53 |
| NMRA | Neumora Therapeutics, Inc. | Milligan Michael Lee | See Remarks | 2025-02-18 | Sell | 1,978 | 1.69 | 3,351 | 2025-02-20 17:14:01 |
| NMRA | Neumora Therapeutics, Inc. | Aurora Daljit Singh | Chief Strategy Officer | 2025-02-18 | Sell | 8,565 | 1.68 | 14,347 | 2025-02-20 17:13:14 |
| NMRA | Neumora Therapeutics, Inc. | Lenz Robert A. | Head of R&D | 2025-02-18 | Sell | 5,614 | 1.67 | 9,383 | 2025-02-20 17:12:34 |
| NMRA | Neumora Therapeutics, Inc. | Pinto Joshua | President | 2025-02-18 | Sell | 8,048 | 1.67 | 13,477 | 2025-02-20 17:11:53 |
| NMRA | Neumora Therapeutics, Inc. | Fust Matthew K | Directior | 2024-10-17 | Sell | 21,788 | 17.03 | 370,962 | 2024-10-18 18:25:19 |
| NMRA | Neumora Therapeutics, Inc. | Fust Matthew K | Directior | 2024-10-17 | Option Exercise | 21,788 | 5.83 | 127,039 | 2024-10-18 18:25:19 |
| NMRA | Neumora Therapeutics, Inc. | Lenz Robert A. | Head of R&D | 2024-10-09 | Sell | 13,823 | 15.06 | 208,110 | 2024-10-11 16:10:14 |
| NMRA | Neumora Therapeutics, Inc. | Lenz Robert A. | Head of R&D | 2024-09-17 | Sell | 41,464 | 11.89 | 492,827 | 2024-09-19 16:35:50 |
| NMRA | Neumora Therapeutics, Inc. | Lenz Robert A. | Head of R&D | 2024-09-12 | Sell | 32,948 | 11.43 | 376,665 | 2024-09-16 16:05:48 |
| NMRA | Neumora Therapeutics, Inc. | Pinto Joshua | Chief Financial Officer | 2024-08-22 | Sell | 84,307 | 11.67 | 984,061 | 2024-08-26 18:17:20 |
| NMRA | Neumora Therapeutics, Inc. | Burow Kristina | Directior 10% Owner | 2023-11-13 | Buy | 35,010 | 11.77 | 412,140 | 2023-11-15 18:55:01 |
| NMRA | Neumora Therapeutics, Inc. | ARCH Venture Partners XII, LLC | 10% Owner | 2023-11-13 | Buy | 35,010 | 11.77 | 412,140 | 2023-11-15 18:54:20 |
| NMRA | Neumora Therapeutics, Inc. | Burow Kristina | Directior 10% Owner | 2023-11-08 | Buy | 140,605 | 10.98 | 1,543,563 | 2023-11-13 19:01:41 |
| NMRA | Neumora Therapeutics, Inc. | ARCH Venture Partners XII, LLC | 10% Owner | 2023-11-08 | Buy | 140,605 | 10.98 | 1,543,563 | 2023-11-13 19:00:04 |
| NMRA | Neumora Therapeutics, Inc. | Burow Kristina | Directior 10% Owner | 2023-11-03 | Buy | 95,694 | 11.49 | 1,099,945 | 2023-11-07 19:00:44 |
| NMRA | Neumora Therapeutics, Inc. | ARCH Venture Partners XII, LLC | 10% Owner | 2023-11-03 | Buy | 95,694 | 11.49 | 1,099,945 | 2023-11-07 18:59:41 |
| NMRA | Neumora Therapeutics, Inc. | Burow Kristina | Directior 10% Owner | 2023-09-28 | Buy | 76,511 | 13.68 | 1,046,848 | 2023-09-29 18:55:02 |
| NMRA | Neumora Therapeutics, Inc. | ARCH Venture Partners XII, LLC | 10% Owner | 2023-09-28 | Buy | 76,511 | 13.68 | 1,046,848 | 2023-09-29 18:53:23 |
| NMRA | Neumora Therapeutics, Inc. | Burow Kristina | Directior 10% Owner | 2023-09-26 | Buy | 58,504 | 11.97 | 700,464 | 2023-09-27 20:19:27 |
| NMRA | Neumora Therapeutics, Inc. | ARCH Venture Partners XII, LLC | 10% Owner | 2023-09-26 | Buy | 58,504 | 11.97 | 700,464 | 2023-09-27 20:18:52 |
| NMRA | Neumora Therapeutics, Inc. | ARCH Venture Partners XII, LLC | 10% Owner | 2023-09-22 | Buy | 100,740 | 11.19 | 1,127,064 | 2023-09-25 21:38:12 |
| NMRA | Neumora Therapeutics, Inc. | Burow Kristina | Directior 10% Owner | 2023-09-22 | Buy | 100,740 | 11.19 | 1,127,064 | 2023-09-25 21:37:20 |
| NMRA | Neumora Therapeutics, Inc. | Burow Kristina | Directior 10% Owner | 2023-09-19 | Buy | 1,500,000 | 17.00 | 25,500,000 | 2023-09-20 06:23:08 |
| NMRA | Neumora Therapeutics, Inc. | ARCH Venture Partners X, LLC | 10% Owner | 2023-09-19 | Buy | 1,500,000 | 17.00 | 25,500,000 | 2023-09-20 06:16:19 |
| NMRA | Neumora Therapeutics, Inc. | ARCH Venture Partners X, LLC | 10% Owner | 2023-09-19 | Buy | 1,500,000 | 17.00 | 25,500,000 | 2023-09-20 06:15:08 |
| NMRA | Neumora Therapeutics, Inc. | Gosebruch Henry O | President & CEO | 2023-09-19 | Buy | 15,000 | 12.62 | 189,371 | 2023-09-19 21:47:02 |
| NMRA | Neumora Therapeutics, Inc. | AMGEN INC | 10% Owner | 2023-09-19 | Buy | 1,764,705 | 17.00 | 29,999,984 | 2023-09-19 19:52:07 |
